The present study investigated the glycosylation state of proteins in lung tissue of a cyclophosphamide-induced model of pulmonary fibrosis in rats. In fibrotic lung, the carbohydrate constituents (total hexose, fucose, sialic acid and hexosamine) of salt-soluble, collagenase, elastase and papain digested glycoproteins were significantly higher compared to normal lungs. Interestingly, fibrotic lung tissues had higher activities of mannosyl, glucosyl, galactosyl, sialyl and fucosyl transferases than normal lung tissues. Similarly, mannosyl, glucosyl, galactosyl, sialyl and fucosyl transferases were higher in serum from rats with fibrosis than in that from normals. These data indicate that glycoprotein metabolism is significantly altered from normal in animals with interstitial lung fibrosis. z
Introduction
Interstitial pulmonary ¢brosis is a chronic in£am-matory interstitial lung disease characterized by the accumulation of alveolar macrophages and more typically of neutrophils and lymphocytes in the lower respiratory tract, followed by parenchymal injury and ¢brosis of the alveolar structure [1] . Histopathology of ¢brotic lung suggests that the lesions are rich in extracellular matrix of connective tissue [2, 3] . In early stages of development, a marked ¢broblast in¢ltrate may be present, while at later stages the lesions are characterized by deposition of dense collagenous meshwork. These observations suggest that ¢brosis results from a localized loss of control in the regulation of extracellular matrix production.
Lung growth, injury and repair are processes that involve major changes in the extracellular matrix and in the cells that produce this matrix [4] . Increased amounts and di¡erent types of collagenous and non-collagenous components characterize the end stages of lung ¢brosis [5^12] . The latter components include glycoproteins which are predominantly protein in nature with one or more heterosaccharide chains containing hexosamines, hexoses, fucose and sialic acid. These conjugated proteins are represented by many substances of biologic importance, including enzymes, hormones, antibodies and membranes. The collagens, major structural proteins of the body, have now been clearly shown to belong to the glycoprotein family.
Whereas collagen, elastin and glycosaminoglycans contents and synthesis in interstitial lung ¢brosis have been reported [5^7,10^12], until now the nature of changes in glycoproteins during the development of lung ¢brosis is not very well understood. Although this connective tissue component com-prises only a small percentage of the extracellular matrix, it may nevertheless play an important role in the pathogenesis of pulmonary ¢brosis by virtue of its ubiquitous presence on cell surfaces and in the extracellular matrix. It has been suggested that the glycoproteins have some function in stabilizing the tissue, and may be involved in maintaining the structural stability of collagen ¢brils [13] . Glycoproteins incorporate into ¢brils during collagen synthesis and play a role in cementing ¢brils into ¢bers, an interaction that accounts for certain biologic properties of ¢bers [14] . In addition, glycoproteins may be the components of connective tissue that are primarily responsible for its antigenic property in tissue transplants [15] . Although carbohydrate moieties of glycoproteins are altered during the progression of lung and liver ¢brosis [16, 17] , the nature of changes taking place in soluble glycoproteins, collagen and elastin associated structural glycoproteins in ¢brotic conditions and their importance have not been completely elucidated until date. Furthermore, a speci¢c and precise analysis of the levels of glycoproteins (in this case carbohydrate moieties) and relevant carbohydrate metabolic enzymes as a measure of glycoprotein metabolism in normal lung and in ¢brotic conditions has not been studied previously. Hence it became of interest to characterize the temporal sequence of changes in the metabolism of lung glycoproteins in experimental interstitial lung ¢brosis induced by cyclophosphamide (CP). Cyclophosphamide has been observed to produce pulmonary ¢-brosis in rats [18] and mice [19] after histologically de¢nable periods of acute injury, cell death and in£ammation [20] . Since the pulmonary morphologic and biochemical alterations induced by CP are similar to those seen in man, we performed our investigations in this experimental model of lung ¢bro-sis.
Materials and methods

Chemicals
Bacterial collagenase, L-mercaptoethanol, chloroform, elastase, methanol, ovomucoid, papain, sialic acid, toluene, trichloroacetic acid and Triton X-100 were purchased from Sigma (St. Louis, MO, USA). 
Experimental design
Male albino rats of Wistar strain kept and inbred in our animal house, weighing about 100 þ 10 g, were used throughout this study. The rats were housed in solid bottomed polyvinyl cages under controlled environmental conditions, i.e. 12 h photoperiod, temperature (20 þ 2³C) and humidity (60^70%). The animals received commercial pellets (Hindustan Lever, Bombay, India) and water ad libitum.
Fibrosis was induced in pathogen-free, healthy male rats by intraperitoneal injection of 20 mg/100 g body weight of CP. CP was given in a small volume of sterile triple distilled water. The control rats were given the same volume of water only. Animals were sacri¢ced (by decapitation under light ether anesthesia) 7, 14, and 28 days after CP injection. Immediately after sacri¢ce lung tissues were removed on ice and processed for biochemical analysis. Blood samples were allowed to clot and the serum was separated for quanti¢cation of enzymes. No statistically signi¢cant di¡erences were observed between the different control groups on days 7, 14 and 28 on any parameters analyzed and hence their pooled value was used as control [17] .
Assessment of lung ¢brosis
Lung ¢brosis was evaluated both histopathologically and biochemically. Lung hydroxyproline, a classical marker of ¢brosis, was determined by the method of Woessner [21] . Ten milligram of lung tissue was hydrolyzed with 6 N hydrochloric acid for 20 h at 110³C, evaporated to dryness, resuspended in triple distilled water and made up to a known volume. The sample was treated with activated charcoal and ¢ltered through Whatman ¢lter paper. The clear ¢ltrate was used for the determination of hydroxyproline. Two milliliter of samples containing 2^10 Wg of hydroxyproline were placed in test tubes. Hydroxyproline oxidation was initiated by adding 1 ml of chloramine-T (0.141 g of chloramine-T in 2 ml of triple distilled water, 3 ml of peroxide-free methyl cellosolve and 5 ml of sodium acetate-citrate bu¡er, pH 6.0) to each tube. The tube contents were vortexed for a few minutes and allowed to stand for 20 min at room temperature. The chloramine-T was then destroyed by adding 1 ml of perchloric acid to each tube. The contents were mixed and allowed to stand for 5 min. Finally 1 ml of p-dimethylaminobenzaldehyde (20%, w/v, in methyl cellosolve, freshly prepared before use) was added and the mixture was shaken. The tubes were placed in a 60³C water bath for 20 min, then cooled in tap water for 5 min. The color developed was read spectrophotometrically at 557 nm.
Preparation of tissue and glycoprotein extraction
Glycoproteins were extracted from the lung samples as outlined in Fig. 1 . Brie£y, the lungs were dissected, rinsed in ice-cold 0.15 M NaCl to remove blood and adherent tissues, weighed and ¢nely minced with scissors. Tissues were homogenized in 0.15 M NaCl (15 ml/g tissue) using a Polytron homogenizer in the cold room at 4³C. Homogenized tissues were kept for shaking in a mechanical shaker at 4³C for 48 h and then allowed to stand for 3 h at 4³C. Supernatants were separated and stored and the residue was reextracted with 0.15 M NaCl. Pooled supernatants were then dialyzed against 0.15 M NaCl for 48 h at 4³C and used for the estimation of carbohydrate constituents of salt-soluble glycoproteins.
The residue after 0.15 M NaCl extraction was subjected to collagenase (120 units/g tissue) digestion in 10 ml of 0.05 M Tris-HCl bu¡er, pH 7.4, containing 0.25 M calcium chloride and 1 mM PMSF, twice for 24 h each at 37³C. The digested samples were centrifuged at 3000Ug to remove the residual material and the supernatant was treated with 5% (w/v) trichloroacetic acid (TCA). The precipitate was separated, dissolved in 0.2 M acetate bu¡er, pH 7.0, containing 2 mg cysteine hydrochloride and digested with crystalline papain (100 mg/g wet tissue) at 65³C for 72 h. The digested material was cooled to 4³C and 4^5 vols. of ethanol were added and left for 24 h with constant shaking and then centrifuged. The supernatant was collected and evaporated to dryness under vacuum. The dried residue was dissolved in distilled water and used for the estimation of glycoproteins.
The residue after collagenase digestion was treated thrice with elastase (0.5 mg/g wet tissue) in 0.2 M Tris-HCl bu¡er, pH 8.8, containing 0.25 M calcium chloride and 1 mM PMSF [22] and extraction was repeated every 24 h. After each extraction, the supernatants were separated by centrifugation at 3000Ug and pooled. The elastase hydrolyzed proteins in the pooled supernatants were precipitated with 5% TCA and further extraction was carried out following the same procedure as described under collagenase solubilization using papain. The residue from the elastase digestion was also subjected to papain digestion at 65³C prior to assay for carbohydrate units of glycoproteins.
Estimation of fucose
Fucose content in the tissue homogenate was determined utilizing the method described by Dische and Shettles [23] . Aliquots of tissue homogenate (1 ml) were added to 4.5 ml of cold sulfuric acid and mixed vigorously. The samples were brought to room temperature, placed in a vigorously boiling water bath (sample tubes must be capped) for exactly 3 min and then cooled to room temperature. Then 0.1 ml of cysteine reagent was added with immediate mixing and the intensity of the color was determined at 396 nm and at 427 nm in a Shimadzu UV-260 spectrophotometer. To avoid hexose interference [17] , the content of fucose in a given sample was determined by subtracting the absorbance di¡erence of the sample between 396 and 427 nm without cysteine from the absorbance di¡erence of the same sample between 396 and 427 nm with cysteine.
Estimation of sialic acid
The content of sialic acid in tissue samples was estimated using thiobarbituric acid as described by Warren [24] . Since this assay measures only free sialic acids [17] , the tissue homogenates were hydrolyzed with 0.1 N sulfuric acid at 80³C for 60 min in a sealed tube. The hydrolyzed samples were mixed with 0.1 ml of periodate solution (0.2 M sodium metaperiodate in 9 M phosphoric acid) and kept at room temperature for 20 min. One milliliter of arsenite solution (10% sodium arsenite in a solution of 0.5 M sodium sulfate in 0.1 N sulfuric acid) was added and the tubes were shaken until the yellowbrown color of the liberated iodine disappeared. Then 3 ml of the thiobarbituric acid solution (0.6% thiobarbituric acid in a 0.5 mM sodium sulfate solution) was added and the contents were mixed thoroughly. The sample tubes were capped and heated in a vigorously boiling water bath for 15 min and cooled under tap water for 5 min. Finally 4.3 ml of cyclohexanone was added and mixed vigorously in order to extract the red color into the organic phase and then centrifuged for 3 min at 1000Ug. The clear top organic phase was transferred to a cuvette and the intensity of the color was determined at 549 nm.
Estimation of total hexose
Total hexose was determined by the method of Dubois et al. [25] using phenol as the speci¢c color developing reagent. To aliquots of the tissue homogenates, 0.05 ml of the phenol reagent (80%, w/v, in distilled water) was added. Then 5 ml of concentrated sulfuric acid was added rapidly and the sample was brought to room temperature. The intensity of the color was measured at 490 nm.
Estimation of hexosamine
Hexosamine in tissue homogenate was determined following the procedure adopted by Boas et al. [26] . Since neutral sugars are present in tissue homogenates, hexosamines were separated from neutral sugars by adsorption and elution from ion-exchange resin (Dowex 50X4, 200^400 mesh H form). Prior to the separation of hexosamines from the ion-exchange column, hexosamines were liberated by acid hydrolysis with 4 N HCl for 8 h in sealed tubes kept in a boiling water bath. The acid from the hydrolyzate was completely removed in a rotary evaporator (Haake-Buchler PE6, Haake-Buchler Instruments, Saddle Brook, NJ, USA) at 50³C prior to placing the samples on the ion-exchange column. The ionexchange resin was washed prior to use with 2 N NaOH, distilled water, 3 N HCl and ¢nally with distilled water, and transferred to the column. The sample was loaded on the top of the column and washed with triple distilled water. The hexosamines were then eluted from the column with 2 N HCl and the eluate was collected, evaporated to dryness at 50³C and dissolved in a known amount of water. One milliliter of this solution was mixed with 1 ml of acetylacetone (2% solution in 1 N sodium carbonate) in a screw capped tube and placed in a boiling water bath for 45 min. After cooling, 2.5 ml of ethanol was added and mixed thoroughly. To this 1 ml of Ehrlich's reagent (2.67%, w/v, of p-dimethylaminobenzaldehyde in a 1:1 mixture of ethanol and concentrated HCl) was added, mixed thoroughly and made up to 10 ml with ethanol. The readings were recorded at 530 nm.
Estimation of glycoprotein transferases 2.10. Microsome preparation
The lungs were minced with scissors and suspended in 0.01 M Tris-HCl bu¡er, pH 7.5, containing 0.025 M potassium chloride, 0.005 M magnesium chloride and 0.25 M sucrose. The suspension was homogenized in a Polytron homogenizer. The homogenate was centrifuged at 12 000Ug for 10 min in a Hitachi refrigerated centrifuge to sediment the cell debris, nuclei and mitochondria. The postmitochondrial supernatant was centrifuged at 105 000Ug for 60 min in an ultracentrifuge (Hitachi, Himac SCP 70G) to obtain the total microsome as a pellet. The microsomes were suspended in Tris-HCl bu¡er and used fresh for the assay of glycoprotein transferases.
Assay for mannosyl and glucosyl transferases
Mannosyl and glucosyl transferases were measured following the procedure of Iusem et al. [27] 
C]mannose. The reaction was allowed to proceed at 30³C for 10 min and then terminated by adding 2 ml chloroform-methanol (3:2, v/v). After removal of the protein pellet by low speed centrifugation, a di¡erential extraction was performed [28] . The lower phase was evaporated and its radioactivity taken as an estimation of the amount of mannosylphosphoryl dolichol formed. For analysis of UDP [
14 C]glucosyl transferase the same procedure was followed except that 0.86 WM UDP [
14 C]glucose was the sugar donor.
Assay for sialyl and galactosyl transferases
Sialyl and galactosyl transferase activities were assayed as described by Fraser et al. [29] . A total volume of 50 Wl contained serum (20 Wl) or lung microsomes (25 Wl), 6 nmol CMP [
14 C]sialic acid, 6.25 nmol MES (2-[N-morpholinoethanesulfonic acid) bu¡er, pH 6.8 and 500 Wg desialofetuin and 0.5% Triton X-100. Incubations were done at 37³C for 60 min and the reaction was terminated by the addition of 1 ml of 5% TCA/1% phosphotungstic acid (PTA) mixture (1:1, v/v). Precipitates were ¢ltered under suction through glass ¢ber ¢lters and washed with 10 ml TCA/PTA and 7 ml of ethanol/ether (1:1, v/v). The discs were dried with ether and measured for radioactivity in a toluene based scintillation solution using a Beckman LS-1701 liquid scintillation counter.
A total volume of 50 Wl contained serum (20 Wl) or lung microsomes (25 Wl) as described above: 3 nmol of UDP [ 14 C]galactose, 6.25 nmol MES bu¡er, pH 6.8 and 250 Wg desialogalactofetuin. Assays were incubated and processed for the measurement of radioactive product as described above.
Assay for fucosyl transferase
Fucosyl transferase activity was assayed by the method of Reddy et al. [30] . The lung tissues were homogenized in 10 vols. of 50 mM (3-[N-morpholinopropanesulfonic acid (MOPS), pH 6.8. The assay system contained 50 mM MOPS bu¡er, pH 6.8, 20 WM GDP [
14 C]fucose, 4 mg of ovomucoid, 5 mM magnesium chloride, 0.1% Triton X-100 and 75 Wg equivalent of tissue homogenate or 0.5^0.7 mg serum protein in a ¢nal volume of 50 Wl. The mixture was incubated for 20 min at 37³C. Blanks containing no enzyme and zero time controls were used for suitable corrections. Following incubation the tubes were placed on ice to terminate the reaction and 2 ml of cold TCA-PTA were immediately added and the tubes were allowed to stand on ice for 10^15 min, centrifuged and washed twice with TCA-PTA mixture followed by one washing with 2 ml of ethanolether (3:1, v/v). The washed precipitate was measured for radioactivity in a toluene based scintillation solution.
The enzyme activity was expressed as nanomoles per hour per 100 mg protein (serum) or micromoles per hour per mg protein (tissue).
Statistical analysis
All data are presented as mean þ S.D. of six observations. The results were statistically evaluated using Student's t-test. Di¡erences were considered to be statistically signi¢cant at the level of P 6 0.05 and P 6 0.01.
Results
Characteristics of cyclophosphamide-treated rats
At a dose of 20 mg/100 g body weight, CP caused a mortality rate of 25% that occurred between the ¢rst and second weeks of injection. Light microscopic examination of the lungs of CP treated rats revealed evidence of interstitial edema, presence of in£ammatory cell in¢ltrate with polymorphonuclear leukocytes and macrophages and ¢broblastic masses occupying alveolar spaces.
Lung hydroxyproline
The time course of the stimulation by CP of collagen (determined as hydroxyproline) synthesis in rat lung is shown in Fig. 2 . A signi¢cant (P 6 0.01) increase in hydroxyproline content in the lung tissue of CP rats was measured on day 14, and by day 28 hydroxyproline content was enhanced as much as 1.75-fold compared to controls. In contrast to the stimulation of collagen synthesis caused by CP at day 14 and day 28, no signi¢cant e¡ect on hydroxyproline content was observed at day 7. Furthermore, the stimulatory e¡ect of CP on collagen synthesis appears to follow after the early increases in carbohydrate constituents of glycoproteins.
Lung glycoprotein composition
The pro¢le of carbohydrate constituents of saltsoluble and salt-resistant glycoproteins is shown in Fig. 3 and Table 1 , respectively. Quantitative comparison of carbohydrates between salt-soluble and -insoluble fractions revealed that sequential proteo- lytic digestion with collagenase, elastase and papain was responsible for the larger amount of glycoproteins released into the digested material of the lung tissue. Biochemical analysis of carbohydrates revealed that ¢brotic lungs contained signi¢cantly (P 6 0.01) more hexose, fucose and sialic acid than did controls at days 7, 14 and 28. However, the increases in carbohydrate constituents at 14 and 28 days were not as prominent as at day 7. In contrast, ¢brotic tissues demonstrated a progressive increase in hexosamine content with increasing time. The signi¢-cance of this observation implies an overall elevation in the biosynthetic pathway leading to nucleotide hexosamine formation as a result of in£ammation [31] , increased synthesis of glycoproteins containing hexosamine, especially laminin [17, 32, 33] , during the early phase of wound healing and subsequent synthesis of glycosaminoglycans [5^9,17] . A similar increase in plasma ¢bronectin and perchlorosoluble serum glycoproteins (determined as sialic acid) has been reported in radiation-induced lung injury in rats [34] . In addition, salt-soluble plasma glycoproteins have been noticed in wounds during the in£am-matory phase [35, 36] . Furthermore, increased fucose content has also been reported in ¢brotic liver [17] . These observations suggest that the early increases in carbohydrate moieties were due to an increased glycoprotein biosynthesis in response to the CP-induced in£ammatory reaction. We believe that the increases in carbohydrate constituents could be associated with the activation of ¢broblasts to divide, proliferate and synthesize non-collagenous glycoproteins and other matrix constituents, a process mediated by a host of substances which include immune complexes, serum components, growth factors and cytokines, following tissue injury and during host in£ammatory response [37, 38] .
Glycoprotein transferases
The activities of serum and lung glycoprotein transferases are shown in Figs. 4 and 5, respectively. Since several studies [29, 32, 39] have demonstrated an association between enhanced glycoprotein biosynthesis following in£ammation and changes in the activities of enzymes involved in their synthesis, we were particularly interested in determining whether the tissue injury and in£ammation noticed after CP insult were accompanied by an increase in glycoprotein transferases. In the present study, we investigated glycoprotein transferases in serum and lung tissues. First, we observed that CP treatment induced an early increase in serum glycoprotein transferases at day 7. Furthermore, we found a marked decrease in these enzymes at day 14 and day 28, but their # Signi¢cantly (P 6 0.05) higher than controls. *Signi¢cantly (P 6 0.01) higher than control rats. # Signi¢cantly (P 6 0.05) higher than controls. *Signi¢cantly (P 6 0.01) higher than control rats. levels were still higher than in controls. Second, the results presented here show that lung glycoprotein transferase activities were elevated at day 7 and continued to rise until day 14, and then declined at day 28. In consideration of the above ¢ndings, it is clear that the glycoprotein biosynthetic machinery is switched on during the early in£ammatory phase of wound healing.
Discussion
Our data demonstrate that changes in the pattern of synthesis of glycoproteins in lung parenchyma occur shortly after cyclophosphamide administration. Although the ¢brotic lung produced a higher proportion of glycoproteins, 7 days after CP administration, a substantial decrease in the amount of soluble glycoprotein content occurred thereafter at day 14 and day 28 post CP. Interestingly, hexosamine levels were elevated in the lungs of CP rats over a 4 week period.
The data reported herein demonstrate a signi¢cant increase in various glycoprotein moieties such as total hexose, fucose, sialic acid and hexosamine as recovered from salt-soluble, collagenase, elastase and papain digested fractions of ¢brotic tissues compared to that of control. This is in agreement with the results of most of the studies which have demonstrated alterations in glycoprotein concentration during in£ammatory conditions, liver ¢brosis, malignancy and in tumorous human lung tissue [17,404 4] . In order to obtain the carbohydrate portion of a glycoprotein with a minimum number of amino acids attached, it is essential to digest extensively with a protease of low speci¢city. Papain is used e¡ectively for the extensive digestion of the peptide portion of glycoproteins. In order to achieve sequential release of sugars from collagen and elastin associated structural glycoproteins, it is necessary to digest sequentially with collagenase and elastase [22] . It could be inferred from the present investigation that not all the glycoproteins are recovered under 0.15 M NaCl extraction and some of the glycoproteins are intimately associated with collagen and elastin. The use of two or more proteolytic enzymes in succession is useful in achieving maximal shortening of the peptide chains. The results reported have indicated that digestion with collagenase and elastase is potentially e¤cient in solubilizing some of the insoluble glycoproteins associated with collagen and elastin and provide more information regarding the glycoprotein moieties associated with these connective tissue proteins. After digestion with these enzymes it may be useful to further reduce the length of peptide chains by digesting with papain. Thus the use of two or more of these enzymes resulted in a high recovery of the carbohydrate material. A greater increase in total hexose in the collagenase digested fraction was observed. However, this is not surprising in view of altered collagen synthesis in ¢brotic conditions [5,45^48] . It is also evident that hexoses are associated more directly with collagen as compared to hexosamine or sialic acid [49] and the increase in the concentration of total hexose may be explained in the presence of increased collagen content and synthesis in ¢brotic conditions. Higher than normal levels of hexosamine were found in ¢brotic lungs. This seems likely to be the result of enhanced synthesis of hexosamine by ¢brotic lungs. The increase in hexosamine content may be interpreted on the basis of increased levels of glycosaminoglycans in lung ¢brosis. Changes in glycosaminoglycans (hexosamine and uronic acid, components of glycosaminoglycans) content have been associated with lung ¢brosis [5^9]. These studies along with the present work demonstrate that altered glycoprotein synthesis is expected to have consequences for the organization of collagen in the tissue, because it is well known to in£uence collagen ¢bril morphology and associations of ¢brils to ¢bers and ¢ber bundles [13, 14, 50] .
It must be emphasized that increases in carbohydrate constituents were more pronounced at day 7 compared to days 14 and 28. However, at later stages in the ¢brotic phase the magnitude of increases in carbohydrates were less than that seen for collagen. It is also clear that there are increases in carbohydrate constituents in the collagenase soluble fraction at day 7 despite no change in collagen content. It is likely that collagenase soluble fractions contain other non-collagenous glycoproteins. Our data demonstrate that distinct metabolic changes occur during tissue repair and ¢brosis in the lung. In early phases of ¢brotic conditions, marked increases in glycoproteins occur. Subsequently, increased levels of collagen occur in the late ¢brotic phase. Thus the di¡er-ences in temporal pattern between glycoproteins and collagen synthesis is consistent with the concept that non-collagenous insoluble structural glycoproteins are produced during the early phase of wound healing. Our results are similar to those of previous studies that have examined the metabolism of non-collagenous glycoproteins during wound healing [51, 52] . Dolynchuk and Bowness [51] have demonstrated that healing wounds synthesize maximum non-collagenous insoluble glycoproteins before the peak in collagen synthesis. Interestingly, ¢bronectin (fucosylated) is involved in the organization of connective tissue matrices, because it not only binds to collagen and glycosaminoglycans, but also acts as a sca¡old for collagen deposition and has many postulated functions in wound healing [53, 54] . In addition, other glycoproteins, namely SPARC (secreted protein acidic and rich in cysteine), tenascin and thrombospondin, are all expressed in pulmonary ¢brosis [55] . We can therefore suggest that the marked early increases in lung glycoprotein content re£ect an early in£ammatory tissue remodeling phase in the process of lung ¢brosis rather than the degree of established end stage disease.
The investigation of the sugar units of glycoproteins has shown evident changes, especially in the concentrations of hexosamine, fucose, sialic acid and hexose, the augmentation of which is proportional to the increase in the concentration and synthesis of corresponding glycoprotein synthesizing enzymes. The observed increases in glycoprotein moieties may be interpreted on the basis of elevated levels of the relevant enzymes in the in£amed state. It must be assumed that the initial response to in£am-mation is the release of some active substance from the site of in£ammation as suggested by Koj [56] . The active substance must operate at the site of synthesis resulting in an increase in synthesis rates, changes in tissue and circulating levels of enzymes involved in the synthesis of carbohydrate portions of glycoprotein, viz. mannosyl, glucosyl, galactosyl, sialyl and fucosyl transferases, would tend to support the above hypothesis. Investigations on the e¡ect of in£ammation on glycoprotein transferases showed a 1.7^3.5-fold increase over a 14 day period as a result of cyclophosphamide injection. It is of great interest that the activity increases sharply during the ¢rst 14 days (lung glycoprotein transferases) after CP insult and then declines progressively from 14 to 28 days after injection; however, serum glycoprotein transferases peaked at day 7 and declined thereafter. Fraser et al. [29] have demonstrated increased sialyl and galactosyl transferase activity in the serum and liver of in£amed rats. Lombart et al. [39] reported that the activity of glucosyl transferase and the rate of transport of N-acetylglucosamine, galactose and sialic acid to an appropriate sugar depleted acceptor glycopeptide were increased during the process of in£ammation. In addition, increased levels of dolichol phosphokinase activity and dolichol phosphate linked glycosylation for mannose and glucose in the liver of in£amed rats have been demonstrated. From the foregoing observations it is evident that enzymes involved in the biosynthesis of glycoproteins are altered during in£ammation. It has to be stressed here that there are no other reports on glycoprotein transferases in experimental lung damage; however, animals with chemically induced liver injury show increased levels of these enzymes [29] .
In summary, our results are the ¢rst to demonstrate that the synthesis of glycoproteins is increased greatly in ¢brotic lungs and suggest that they are sequelae of an in£ammatory process during the development of ¢brosis. The present work also supports the concept that signi¢cant metabolic activity precedes the period of maximum collagen production during in£ammatory conditions and that non-collagenous insoluble structural glycoproteins are produced during the early phase of ¢brosis or wound healing.
